PRESTIGE CONSUMER HEALTHCARE INC. (PBH) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $563.00K; Additional Paid in CapitalUSD $612.51M; Treasury Stock, Common, ValueUSD $441.96M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $562.00K; Additional Paid in CapitalUSD $608.52M; Treasury Stock, Common, ValueUSD $439.30M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $562.00K; Additional Paid in CapitalUSD $605.50M; Treasury Stock, Common, ValueUSD $438.55M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $562.00K; Additional Paid in CapitalUSD $602.76M; Treasury Stock, Common, ValueUSD $392.23M.
PRESTIGE CONSUMER HEALTHCARE INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Treasury Stock, Value, Acquired, Par Value Method USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $563.00K | $612.51M | $441.96M | $-29.68M | $1.78B | $1.92B | 8.94M | 3 month · $2.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $562.00K | $608.52M | $439.30M | $-28.37M | $1.75B | $1.89B | 8.89M | 12 month · $162.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $562.00K | $605.50M | $438.55M | $-30.23M | $1.69B | $1.83B | 8.88M | 3 month · $46.32M 9 month · $161.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $562.00K | $602.76M | $392.23M | $-31.60M | $1.65B | $1.82B | 8.11M | 3 month · $75.90M 6 month · $115.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $561.00K | $600.24M | $316.33M | $-32.26M | $1.60B | $1.86B | 6.96M | 3 month · $39.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $560.00K | $593.40M | $277.21M | $-37.66M | $1.56B | $1.83B | 6.50M | 12 month · $57.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $559.00K | $588.21M | $265.84M | $-40.16M | $1.51B | $1.79B | 6.36M | 3 month · $2.35M 9 month · $46.22M | 3 month · $2.87M 9 month · $8.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $557.00K | $576.60M | $263.50M | $-26.54M | $1.44B | $1.73B | 6.33M | 3 month · $11.93M 6 month · $43.88M | 3 month · $2.13M 6 month · $5.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $557.00K | $572.85M | $251.57M | $-31.34M | $1.39B | $1.68B | 6.16M | 3 month · $31.95M | 3 month · $3.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $555.00K | $567.45M | $219.62M | $-34.49M | $1.34B | $1.66B | 5.68M | 12 month · $30.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $553.00K | $556.45M | $219.64M | $-28.53M | $1.29B | $1.60B | 5.68M | 9 month · $30.52M | 3 month · $2.45M 9 month · $10.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $552.00K | $552.37M | $219.66M | $-35.99M | $1.24B | $1.54B | 5.68M | 6 month · $30.55M | 3 month · $3.69M 6 month · $7.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $552.00K | $546.53M | $219.71M | $-32.21M | $1.19B | $1.48B | 5.68M | 3 month · $30.59M | 3 month · $4.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $548.00K | $535.36M | $189.11M | $-31.56M | $1.13B | $1.45B | 5.17M | 12 month · $55.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $548.00K | $532.51M | $189.11M | $-29.49M | $1.37B | $1.69B | 5.17M | 3 month · $16.00K 9 month · $55.47M | 3 month · $2.43M 9 month · $9.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $547.00K | $524.39M | (m) | $-36.46M | $1.32B | $1.62B | (m) | 3 month · $12.27M 6 month · $55.45M | 3 month · $3.47M 6 month · $7.32M | $189.10M | (m) | (m) | (m) | (m) | (m) | (m) | 5.16M |
| 2022-06-30 | $0.00 | $547.00K | $520.93M | (m) | $-29.34M | $1.27B | $1.58B | (m) | 3 month · $43.18M | 3 month · $3.86M | $176.82M | (m) | (m) | (m) | (m) | (m) | (m) | 4.93M |
| 2022-03-31 | $0.00 | $544.00K | $515.58M | $133.65M | $-19.03M | $1.21B | $1.58B | 4.15M | 12 month · $2.92M | (m) | $133.65M | (m) | (m) | (m) | (m) | (m) | (m) | 4.15M |
| 2021-12-31 | $0.00 | $543.00K | $512.55M | (m) | $-23.21M | $1.16B | $1.52B | (m) | 9 month · $2.92M | 3 month · $2.23M 9 month · $7.33M | $133.65M | (m) | (m) | (m) | (m) | (m) | (m) | 4.15M |
| 2021-09-30 | $0.00 | $542.00K | $507.31M | (m) | $-24.42M | $1.11B | $1.46B | (m) | 6 month · $2.92M | 3 month · $3.22M 6 month · $5.10M | $133.65M | (m) | (m) | (m) | (m) | (m) | (m) | 4.15M |
| 2021-06-30 | $0.00 | $542.00K | $503.59M | (m) | $-20.77M | $1.07B | $1.42B | (m) | 3 month · $2.92M | 3 month · $1.88M | $133.65M | (m) | (m) | (m) | (m) | (m) | (m) | 4.15M |
| 2021-03-31 | $0.00 | $540.00K | $499.51M | (m) | $-19.80M | $1.01B | $1.36B | (m) | 12 month · $13.11M | (m) | $130.73M | (m) | (m) | (m) | (m) | (m) | (m) | 4.09M |
| 2020-12-31 | $0.00 | $539.00K | $495.38M | (m) | $-17.23M | $973.27M | $1.32B | (m) | 3 month · $8.88M 9 month · $11.12M | 3 month · $1.59M 9 month · $5.94M | $128.74M | (m) | (m) | (m) | (m) | (m) | (m) | 4.03M |
| 2020-09-30 | $0.00 | $539.00K | $493.76M | (m) | $-28.61M | $932.40M | $1.28B | (m) | 3 month · $997.00K 6 month · $2.24M | 3 month · $2.89M 6 month · $4.36M | $119.86M | (m) | (m) | (m) | (m) | (m) | (m) | 3.78M |
| 2020-06-30 | $0.00 | $539.00K | $490.80M | (m) | $-33.26M | $887.81M | $1.23B | (m) | 3 month · $1.24M | 3 month · $1.46M | $118.86M | (m) | (m) | (m) | (m) | (m) | (m) | 3.75M |
| 2020-03-31 | $0.00 | $538.00K | $488.12M | (m) | $-44.16M | $844.10M | $1.17B | (m) | 12 month · $57.70M | (m) | $117.62M | (m) | (m) | (m) | (m) | (m) | (m) | 3.72M |
| 2019-12-31 | $0.00 | $537.00K | $485.84M | (m) | $-26.06M | $807.05M | $1.16B | (m) | 3 month · $94.00K 9 month · $50.95M | 3 month · $1.78M 9 month · $5.68M | $110.88M | (m) | (m) | 9 month · 1.62M | 9 month · 30.80 | (m) | (m) | 3.52M |
| 2019-09-30 | $0.00 | $537.00K | $483.60M | (m) | $-29.55M | $769.00M | $1.11B | (m) | 3 month · $21.29M 6 month · $50.86M | 3 month · $2.52M 6 month · $3.90M | $110.78M | (m) | (m) | 3 month · 672.72K 6 month · 1.62M | 3 month · 31.53 6 month · 30.80 | (m) | (m) | 3.52M |
| 2019-06-30 | $0.00 | $537.00K | $480.81M | (m) | $-25.97M | $735.75M | $1.10B | (m) | 3 month · $29.57M | 3 month · $1.38M | $89.49M | (m) | (m) | 3 month · 949.83K | 3 month · 30.29 | (m) | (m) | 2.85M |
| 2019-03-31 | $0.00 | $536.00K | $479.15M | (m) | $-25.75M | $701.82M | $1.10B | (m) | 12 month · $52.26M | (m) | $59.93M | (m) | 12 month · $50.00M | 12 month · 1.45M | 12 month · 34.47 | (m) | (m) | 1.87M |
| 2018-12-31 | $0.00 | $536.00K | $477.87M | (m) | $-26.45M | $841.09M | $1.23B | (m) | 9 month · $52.26M | 3 month · $1.83M 9 month · $6.16M | $59.93M | (m) | (m) | 9 month · 1.45M | 9 month · 34.47 | (m) | (m) | 1.87M |
| 2018-09-30 | $0.00 | $536.00K | $474.14M | (m) | $-24.43M | $802.93M | $1.19B | (m) | 6 month · $52.26M | 3 month · $2.67M 6 month · $4.33M | $59.93M | (m) | (m) | 6 month · 1.45M | 6 month · 34.47 | (m) | (m) | 1.87M |
| 2018-06-30 | $0.00 | $536.00K | $471.32M | (m) | $-22.29M | $772.09M | $1.16B | (m) | 3 month · $52.26M | 3 month · $1.66M | $59.93M | (m) | (m) | 3 month · 1.45M | 3 month · 34.47 | (m) | (m) | 1.87M |
| 2018-04-01 | (m) | (m) | (m) | (m) | (m) | $737.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $534.00K | $468.78M | (m) | $-19.32M | $736.28M | $1.18B | (m) | 12 month · $1.07M | (m) | $7.67M | (m) | (m) | (m) | (m) | (m) | (m) | 353.00K |
| 2017-12-31 | $0.00 | $534.00K | $466.63M | (m) | $-18.02M | $775.96M | $1.22B | (m) | (m) | (m) | $7.67M | (m) | (m) | (m) | (m) | (m) | (m) | 353.00K |
| 2017-09-30 | $0.00 | $534.00K | $464.45M | (m) | $-22.52M | $461.17M | $895.97M | (m) | (m) | (m) | $7.67M | (m) | (m) | (m) | (m) | (m) | (m) | 353.00K |
| 2017-06-30 | $0.00 | $533.00K | $460.40M | (m) | $-25.23M | $430.47M | $858.55M | (m) | (m) | (m) | $7.62M | (m) | (m) | (m) | (m) | (m) | (m) | 352.00K |
| 2017-03-31 | $0.00 | $533.00K | $458.25M | (m) | $-26.35M | $396.71M | $822.55M | (m) | 12 month · $1.43M | (m) | $6.59M | (m) | (m) | (m) | (m) | (m) | 12 month · $900.00K | 332.00K |
| 2016-12-31 | $0.00 | $532.00K | $455.68M | (m) | $-35.38M | $385.62M | $799.86M | (m) | (m) | (m) | $6.59M | (m) | (m) | (m) | (m) | (m) | (m) | 332.00K |
| 2016-09-30 | $0.00 | $532.00K | $453.34M | (m) | $-26.65M | $353.98M | $774.64M | (m) | (m) | (m) | $6.56M | (m) | (m) | (m) | (m) | (m) | (m) | 331.00K |
| 2016-06-30 | $0.00 | $532.00K | $451.07M | (m) | $-29.35M | $321.78M | $737.48M | (m) | (m) | (m) | $6.56M | $-29.35M | (m) | (m) | (m) | $-29.35M | (m) | 331.00K |
| 2016-03-31 | $0.00 | $530.00K | $445.18M | (m) | $-23.52M | $327.31M | $744.34M | (m) | 12 month · $1.69M | (m) | $5.16M | $-23.52M | (m) | (m) | (m) | $-23.52M | 12 month · $1.96M | 306.00K |
| 2015-12-31 | $0.00 | $530.00K | $442.13M | (m) | $-29.97M | $313.38M | $720.94M | (m) | (m) | (m) | $5.12M | $-29.97M | (m) | (m) | (m) | $-29.97M | (m) | 306.00K |
| 2015-09-30 | $0.00 | $530.00K | $439.86M | (m) | $-34.90M | $285.38M | $685.75M | (m) | (m) | (m) | $5.12M | $-34.90M | (m) | (m) | (m) | $-34.90M | (m) | 306.00K |
| 2015-06-30 | $0.00 | $530.00K | $437.55M | (m) | $-23.82M | $253.58M | $662.72M | (m) | (m) | (m) | $5.12M | $-23.82M | (m) | (m) | (m) | $-23.82M | (m) | 306.00K |
| 2015-03-31 | $0.00 | $525.00K | $426.58M | (m) | $-23.41M | $227.41M | $627.62M | (m) | 12 month · $2.05M | (m) | $3.48M | $-23.41M | (m) | (m) | (m) | $-23.41M | 12 month · $1.33M | 266.00K |
| 2014-12-31 | $0.00 | $525.00K | $423.99M | (m) | $-16.14M | $203.63M | $608.94M | (m) | (m) | (m) | $3.06M | $-16.14M | (m) | (m) | (m) | $-16.14M | (m) | 255.00K |
| 2014-09-30 | $0.00 | $524.00K | $421.57M | (m) | $-7.37M | $182.34M | $594.04M | (m) | (m) | (m) | $3.03M | $-7.37M | (m) | (m) | (m) | $-7.37M | (m) | 254.00K |
| 2014-06-30 | $0.00 | $522.00K | $418.49M | (m) | $3.46M | $165.88M | $585.81M | (m) | (m) | (m) | $2.54M | $3.46M | (m) | (m) | (m) | $3.46M | (m) | 240.00K |
| 2014-03-31 | $0.00 | $520.00K | $414.39M | (m) | $739.00K | $149.15M | $563.36M | (m) | 12 month · $744.00K | (m) | $1.43M | $739.00K | (m) | (m) | (m) | $739.00K | 12 month · $1.65M | 206.00K |
| 2013-12-31 | $0.00 | $520.00K | $412.91M | (m) | $-1.68M | $132.86M | $543.93M | (m) | (m) | (m) | $965.00K | $-1.68M | (m) | (m) | (m) | $-1.68M | (m) | 194.00K |
| 2013-09-30 | $0.00 | $520.00K | $410.66M | (m) | $1.02M | $129.73M | $541.25M | (m) | (m) | (m) | $965.00K | $1.02M | (m) | (m) | (m) | $1.02M | (m) | 191.00K |
| 2013-06-30 | $0.00 | $514.00K | $403.64M | (m) | $-103.00K | $96.94M | $500.31M | (m) | (m) | (m) | $965.00K | $1.00K | (m) | (m) | (m) | $1.00K | (m) | 191.00K |
| 2013-03-31 | $0.00 | $513.00K | $401.69M | (m) | $-104.00K | $76.25M | $477.94M | (m) | (m) | (m) | $687.00K | $-104.00K | (m) | (m) | (m) | $-104.00K | (m) | 181.00K |
| 2012-12-31 | $0.00 | $512.00K | $400.32M | (m) | $10.00K | $56.90M | $457.33M | (m) | (m) | (m) | $687.00K | $10.00K | (m) | (m) | (m) | (m) | (m) | 181.00K |
| 2012-09-30 | $0.00 | $505.00K | $393.95M | (m) | $11.00K | $44.64M | $438.70M | (m) | (m) | (m) | $687.00K | $11.00K | (m) | (m) | (m) | (m) | (m) | 181.00K |
| 2012-06-30 | $0.00 | $505.00K | $392.89M | (m) | $-55.00K | $25.40M | $418.33M | (m) | (m) | (m) | $687.00K | $-55.00K | (m) | (m) | (m) | (m) | (m) | 181.00K |
| 2012-03-31 | $0.00 | $505.00K | $391.90M | (m) | $-13.00K | $10.74M | $402.73M | (m) | (m) | (m) | $687.00K | $-91.00K | (m) | (m) | (m) | $-91.00K | (m) | 181.00K |
| 2011-12-31 | $0.00 | $504.00K | $390.86M | (m) | $-70.00K | $11.04M | $401.65M | (m) | (m) | (m) | $687.00K | (m) | (m) | (m) | (m) | (m) | (m) | 181.00K |
| 2011-09-30 | $0.00 | $504.00K | $390.16M | (m) | $-52.00K | $1.53M | $391.45M | (m) | (m) | (m) | $687.00K | (m) | (m) | (m) | (m) | (m) | (m) | 181.00K |
| 2011-06-30 | $0.00 | $504.00K | $389.36M | (m) | $-10.00K | $-11.42M | $377.74M | (m) | (m) | (m) | $687.00K | (m) | (m) | (m) | (m) | (m) | (m) | 181.00K |
| 2011-03-31 | $0.00 | $503.00K | $387.93M | (m) | $0.00 | $-26.19M | $361.83M | (m) | (m) | (m) | $416.00K | (m) | (m) | (m) | (m) | (m) | (m) | 160.00K |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $329.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $294.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |